Yep, revenue from $34M to $32M by my count, not much to worry about really.
It would have been nice to know what the margin was on that lost revenue, were we losing money selling these products? If so, then it would be a positive, the downer is they are now moving the target for CF+ into 2019 which is bullshit to me.
Seems to me like they are using this as cover for the increased R&D spent this year.
Ann: Conclusion of relationship with Go Medical Industries, page-12
-
- There are more pages in this discussion • 156 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.15 |
Change
0.350(2.97%) |
Mkt cap ! $256.8M | |||
| Open | High | Low | Value | Volume |
| $11.80 | $12.15 | $11.21 | $376.0K | 32.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 139 | $12.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.15 | 830 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |